Michael Hernandez on April 29, 2026 7:31 am Silver leverage is strong here; beta cuts both ways though. Reply
William Martin on April 29, 2026 7:33 am Exploration results look promising, but permitting will be the key risk. Reply
Emma Miller on April 29, 2026 7:33 am Silver leverage is strong here; beta cuts both ways though. Reply
Isabella Rodriguez on April 29, 2026 7:33 am Silver leverage is strong here; beta cuts both ways though. Reply
Ava Thompson on April 29, 2026 7:34 am Interesting update on Neuroscientist Reveals the Dark Side of Brain Implants. Curious how the grades will trend next quarter. Reply
Isabella J. Martinez on April 29, 2026 7:34 am Exploration results look promising, but permitting will be the key risk. Reply
Michael Jones on April 29, 2026 7:34 am I like the balance sheet here—less leverage than peers. Reply
Liam P. Taylor on April 29, 2026 7:35 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
James Smith on April 29, 2026 7:38 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Michael Williams on April 29, 2026 7:38 am Uranium names keep pushing higher—supply still tight into 2026. Reply
Olivia M. Smith on April 29, 2026 7:38 am I like the balance sheet here—less leverage than peers. Reply
Ava White on April 29, 2026 7:39 am Production mix shifting toward Videos might help margins if metals stay firm. Reply
Mary Johnson on April 29, 2026 7:40 am Silver leverage is strong here; beta cuts both ways though. Reply
William Lopez on April 29, 2026 7:40 am Exploration results look promising, but permitting will be the key risk. Reply
Mary K. Miller on April 29, 2026 7:41 am If AISC keeps dropping, this becomes investable for me. Reply
Patricia Martin on April 29, 2026 7:42 am Exploration results look promising, but permitting will be the key risk. Reply
James Jackson on April 29, 2026 7:42 am Exploration results look promising, but permitting will be the key risk. Reply
Patricia Brown on April 29, 2026 7:42 am Interesting update on Neuroscientist Reveals the Dark Side of Brain Implants. Curious how the grades will trend next quarter. Reply
Elizabeth Brown on April 29, 2026 7:43 am Exploration results look promising, but permitting will be the key risk. Reply
Michael Q. Lee on April 29, 2026 7:43 am The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Noah Garcia on April 29, 2026 7:43 am Interesting update on Neuroscientist Reveals the Dark Side of Brain Implants. Curious how the grades will trend next quarter. Reply
Ava N. Davis on April 29, 2026 7:44 am Silver leverage is strong here; beta cuts both ways though. Reply
44 Comments
Silver leverage is strong here; beta cuts both ways though.
Exploration results look promising, but permitting will be the key risk.
Silver leverage is strong here; beta cuts both ways though.
Silver leverage is strong here; beta cuts both ways though.
Interesting update on Neuroscientist Reveals the Dark Side of Brain Implants. Curious how the grades will trend next quarter.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Uranium names keep pushing higher—supply still tight into 2026.
I like the balance sheet here—less leverage than peers.
If AISC keeps dropping, this becomes investable for me.
Production mix shifting toward Videos might help margins if metals stay firm.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on Neuroscientist Reveals the Dark Side of Brain Implants. Curious how the grades will trend next quarter.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Interesting update on Neuroscientist Reveals the Dark Side of Brain Implants. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.